fosinopril has been researched along with Body Weight in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, H; Li, P; Liang, Q; Lu, J; Luo, G; Wang, Y; Yin, T; Zhang, H; Zhang, X; Zhao, T | 1 |
| Bartels, T; Dominiak, P; Häuser, W; Raasch, W; Rütten, H; Schwartz, C | 1 |
| Burrell, LM; Cooper, ME; Jaworski, K; Kubota, E; Mifsud, SA; Wilkinson-Berka, JL | 1 |
| Rösen, P; Rösen, R; Rump, AF | 1 |
| García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Cheung, BM; Lau, CP | 1 |
| Intengan, HD; Li, JS; Schiffrin, EL; Thibault, G | 1 |
| Bitzur, R; Grossman, E; Harats, D; Levkovitz, H; Shaish, A; Sharabi, Y; Sherer, Y | 1 |
| Allemann, Y; Baumann, S; Ferrari, P; Jost, M; Riesen, W; Shaw, S; Weidmann, P | 1 |
2 trial(s) available for fosinopril and Body Weight
| Article | Year |
|---|---|
Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Weight; Double-Blind Method; Echocardiography; Electrocardiography; Electrolytes; Female; Fosinopril; Heart Rate; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Peptidyl-Dipeptidase A; Placebos; Urine | 1999 |
Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Body Weight; Fosinopril; Humans; Insulin; Lipoproteins; Male; Proline; Radioimmunoassay; Reference Values; Triglycerides | 1992 |
7 other study(ies) available for fosinopril and Body Weight
| Article | Year |
|---|---|
Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fosinopril; Gas Chromatography-Mass Spectrometry; Humans; Hypertrophy; Kidney Cortex; Male; Metabolomics; Proteinuria; Rats; Rats, Wistar; Toxins, Biological | 2012 |
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Fosinopril; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR | 2002 |
Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Body Weight; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Hypertension; Kidney; Male; Models, Cardiovascular; Neprilysin; Pyridines; Rats; Renin; Statistics as Topic; Survival Analysis; Systole; Thiazepines; Time Factors; Treatment Outcome | 2004 |
Influence of angiotensin-converting enzyme inhibition by fosinopril on myocardial perfusion in streptozotocin-diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Experimental; Fosinopril; Heart; Hemodynamics; Male; Rats; Streptozocin; Vascular Resistance | 1996 |
Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Glucose; Blood Pressure; Body Weight; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Epoprostenol; Fosinopril; Kidney Glomerulus; Male; Multivariate Analysis; Rats; Rats, Wistar | 1997 |
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Collagen; Elastin; Fosinopril; Hypertension; Integrins; Irbesartan; Male; Mesenteric Arteries; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vascular Resistance | 1999 |
The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Fosinopril; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Renin-Angiotensin System; Sinus of Valsalva; Triglycerides | 2000 |